A novel DNA vaccine for reduction of PRRSV-induced negative immunomodulatory effects: A proof of concept

Vaccine

Volumn 33, Issue 32, 2015, Pages 3997-4003

  Suradhat, Sanipa ^a   Wongyanin, Piya ^a,c   Kesdangsakonwut, Sawang ^a   Teankum, Komkrich ^a   Lumyai, Mongkol ^b   Triyarach, Sittikorn ^b,d   Thanawongnuwech, Roongroje ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Thai Denmark Swine Breeder Public Company Limited   (Thailand)

^c BANSOMDEJCHAOPRAYA RAJABHAT UNIVERSITY   (Thailand)

^d ZOETIS   (United States)

Author keywords

DNA vaccine; Nucleocapsid protein; PRRSV; Tregs

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 10; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; NUCLEOCAPSID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; EXPERIMENTAL PIG; HUMORAL IMMUNITY; IMMUNOMODULATION; LYMPHOCYTE COUNT; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SEROCONVERSION; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOLOGY; PIG; TREATMENT OUTCOME;

ANIMALS; IMMUNE TOLERANCE; MALE; NUCLEOCAPSID PROTEINS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; TREATMENT OUTCOME; VACCINES, DNA;

EID: 84937515643     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.06.020     Document Type: Article

References (33)

1. Van Reeth K., Nauwynck H. Proinflammatory cytokines and viral respiratory disease in pigs. Vet Res 2000, 31:187-213.
2. Thanawongnuwech R., Brown G.B., Halbur P.G., Roth J.A., Royer R.L., Thacker B.J. Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection. Vet Pathol 2000, 37:143-152.
3. Lopez O.J., Osorio F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol 2004, 102:155-163.
4. Mateu E., Diaz I. The challenge of PRRS immunology. Vet J 2008, 117:345-351.
5. Cecere T.E., Todd S.M., Leroith T. Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?. Viruses 2012, 4:833-846.
6. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., et al. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet Microbiol 2007, 123:69-85.
7. Martelli P., Gozio S., Ferrari L., Rosina S., De Angelis E., Quintavalla C., et al. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity. Vaccine 2009, 27:3788-3799.
8. Yoo D., Song C., Sun Y., Du Y., Kim O., Liu H.C. Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus. Virus Res 2010, 154:48-60.
9. Thanawongnuwech R., Suradhat S. Virus Res 2010, 154:133-140.
10. Snijder E.J., Kikkert M., Fang Y. Arterivirus molecular biology and pathogenesis. J Gen Virol 2013, 94:2141-2163.
11. Huang C., Zhang Q., Feng W.H. Regulation and evasion of antiviral immune responses by porcine reproductive and respiratory syndrome virus. Virus Res 2015, 202:101-111.
12. Meng X.J. Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficiency and future vaccine development. Vet Microbiol 2000, 74:309-329.
13. Meier W.A., Galeota J., Osorio F.A., Husmann R.J., Schnitzlein W.M., Zuckermann F.A. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology 2003, 309:18-31.
14. Suradhat S., Kesdangsakonwut S., Sada W., Buranapraditkun S., Wongsawang S., Thanawongnuwech R. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine. Vaccine 2006, 24:2634-2642.
15. Wongyanin P., Buranapraditkul S., Yoo D., Thanawongnuwech R., Roth J.A., Suradhat S. Role of porcine reproductive and respiratory syndrome virus nucleocapsid protein in induction of interleukin-10 and regulatory T-lymphocytes (Treg). J Gen Virol 2012, 93:1236-1246.
16. Silva-Campa E., Flores-Mendoza L., Resendiz M., Pinelli-Saavedra A., Mata-Haro V., Mwangi W., et al. Induction of T helper 3 regulatory cells by dendritic cells infected with porcine reproductive and respiratory syndrome virus. Virology 2009, 387:373-379.
17. LeRoith T., Hammond S., Todd S.M., Ni Y., Cecere T., Pelzer K.D. A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae. Vet Immunol Immunopathol 2011, 140:312-316.
18. Nelson E.A., Christopher-Hennings J., Benfield D.A. Serum immune responses to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus. J Vet Diagn Invest 1994, 6:410-415.
19. Dea S., Gagnon C.A., Mardassi H., Pirzadeh B., Rogan D. Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Arch Virol 2000, 145:659-688.
20. Liu X., Fan B., Bai J., Wang H., Li Y., Jiang P. The NN non-covalent domain of the nucleocapsid protein of type 2 porcine reproductive and respiratory syndrome virus enhances induction of IL-10 expression. J Gen Virol 2015, 96:1276-1286.
21. Sagong M., Lee C. Porcine reproductive and respiratory syndrome virus nucleocapsid protein modulates interferon-beta production by inhibiting IRF3 activation in immortalized porcine alveolar macrophages. Arch Virol 2011, 156:2187-2195.
22. Cancel-Tirado S.M., Evans R.B., Yoon K.J. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection. Vet Immunol Immunopathol 2004, 102:249-262.
23. Thanawongnuwech R., Amonsin A., Tasanakit A., Damrongwatanapokin S. Genetics and geographical variation of porcine reproductive and respiratory syndrome virus (PRRSV) in Thailand. Vet Microbiol 2004, 101:9-21.
24. Thanawongnuwech R., Halbur P.G., Ackermann M.R., Thacker E.L., Royer R.L. Effects of low (modified-live virus vaccine) and high (VR-2385) virulence strains of porcine reproductive and respiratory syndrome virus (PRRSV) on pulmonary clearance of copper particles in pigs. Vet Pathol 1998, 35:398-406.
25. Egli C., Thur B., Liu L., Hofmann M.A. Quantitative TaqMan RT-PCR for the detection and differentiation of European and North American strains of porcine reproductive and respiratory syndrome virus. J Virol Methods 2001, 98:63-75.
26. + regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV). Vet Immunol Immunopathol 2010, 133:170-182.
27. Plagemann P.G. Peptide ELISA for measuring antibodies to N-protein of porcine reproductive and respiratory syndrome virus. J Virol Methods 2006, 134:99-118.
28. Xue Q., Zhao Y.G., Zhou Y.J., Qiu H.J., Wang Y.F., Wu D.L., et al. Immune responses of swine following DNA immunization with plasmids encoding porcine reproductive and respiratory syndrome virus ORFs 5 and 7, and porcine IL-2 and IFNgamma. Vet Immunol Immunopathol. 2004, 102:291-298.
29. Rompato G., Ling E., Chen Z., Van Kruiningen H., Garmendia A.E. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine. Vet Immunol Immunopathol 2006, 109:151-160.
30. Diaz I., Pujols J., Ganges L., Gimeno M., Darwich L., Domingo M., et al. In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus. Vaccine 2009, 27:5603-5611.
31. Charerntantanakul W., Kasinrerk W. Interleukin-10 antisense oligodeoxynucleotide suppresses IL-10 expression and effects on proinflammatory cytokine responses to porcine reproductive and respiratory syndrome virus. Viral Immunol 2010, 23:425-435.
32. Charerntantanakul W., Kasinrerk W. Plasmids expressing interleukin-10 short hairpin RNA mediate IL-10 knockdown and enhance tumor necrosis factor alpha and interferon gamma expressions in response to porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 2012, 146:159-168.
33. Charerntantanakul W. Porcine reproductive and respiratory syndrome virus vaccines: immunogenicity, efficacy and safety aspects. World J Virol 2012, 1:23-30.